While new discoveries in medicine have fueled the drug development industry, our ability to control costs and broaden access to drugs has decreased. What is the role of academic medical centers to control such costs? How can our basic science knowledge and impact on healthcare policy contribute to lowering drug costs? Moderated by Carolyn Johnson, The Washington Post reporter who covers the intersection between business and health. Panelists: Jeremy Greene, M.A., M.D., Ph.D. and Redonda Miller, M.B.A., M.D. #JHMBootCamp
View more from the 2018 Science Writers' Boot Camp at: [ Ссылка ]
